LEO, Eliana Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.395
AS - Asia 8.828
EU - Europa 8.003
SA - Sud America 1.315
AF - Africa 199
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 15
Totale 34.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.119
SG - Singapore 2.629
GB - Regno Unito 2.583
CN - Cina 2.477
IT - Italia 1.606
VN - Vietnam 1.063
HK - Hong Kong 1.052
SE - Svezia 1.039
BR - Brasile 1.021
DE - Germania 637
FR - Francia 370
UA - Ucraina 360
FI - Finlandia 358
RU - Federazione Russa 351
KR - Corea 305
TR - Turchia 278
IN - India 258
BG - Bulgaria 151
CA - Canada 122
AR - Argentina 114
BD - Bangladesh 109
NL - Olanda 105
ID - Indonesia 98
MX - Messico 88
JP - Giappone 79
BE - Belgio 76
IQ - Iraq 70
ZA - Sudafrica 61
PL - Polonia 54
ES - Italia 49
PK - Pakistan 47
AE - Emirati Arabi Uniti 46
IR - Iran 43
EC - Ecuador 42
IE - Irlanda 40
PH - Filippine 38
AU - Australia 37
CO - Colombia 37
LT - Lituania 34
CL - Cile 33
MA - Marocco 32
RO - Romania 28
CH - Svizzera 24
MY - Malesia 24
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
KE - Kenya 22
TW - Taiwan 22
VE - Venezuela 22
EG - Egitto 21
PY - Paraguay 19
TH - Thailandia 19
TN - Tunisia 19
AZ - Azerbaigian 17
JO - Giordania 17
NP - Nepal 16
SA - Arabia Saudita 16
IL - Israele 15
PT - Portogallo 15
AT - Austria 14
NZ - Nuova Zelanda 14
PA - Panama 14
DZ - Algeria 13
PE - Perù 13
GR - Grecia 12
EU - Europa 10
JM - Giamaica 10
KZ - Kazakistan 10
DK - Danimarca 9
RS - Serbia 9
HU - Ungheria 8
UY - Uruguay 8
AL - Albania 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
LK - Sri Lanka 7
PS - Palestinian Territory 7
BY - Bielorussia 6
EE - Estonia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KG - Kirghizistan 5
SY - Repubblica araba siriana 5
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
MN - Mongolia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
HN - Honduras 3
Totale 34.757
Salva come PNG Salva come JPEG
Città #
Southend 1.754
Singapore 1.709
Santa Clara 1.668
Ashburn 1.346
Fairfield 1.242
Chandler 1.067
Hong Kong 1.024
Woodbridge 944
Hefei 798
Jacksonville 710
Houston 689
Dearborn 572
Nyköping 523
Ann Arbor 521
San Jose 521
Wilmington 505
Seattle 466
Beijing 458
Cambridge 428
London 367
Ho Chi Minh City 338
Chicago 327
Los Angeles 303
Modena 281
Hanoi 270
Seoul 267
The Dalles 247
Council Bluffs 225
Helsinki 225
New York 158
Izmir 152
Princeton 149
Sofia 141
Lauterbourg 127
Eugene 126
Salt Lake City 122
San Diego 118
Moscow 109
Milan 106
Bremen 94
Buffalo 93
Shanghai 82
São Paulo 81
Dallas 80
Redwood City 73
Frankfurt am Main 70
Tampa 62
Da Nang 61
Fremont 61
Munich 59
Columbus 57
Brussels 55
Orem 54
Rome 54
Tokyo 54
Des Moines 51
Elk Grove Village 46
Jakarta 45
Warsaw 43
Bologna 40
Guangzhou 35
Ottawa 34
Dublin 33
Mexico City 33
Rio de Janeiro 33
Chennai 31
Falls Church 31
Haiphong 31
Lancaster 31
Mumbai 31
Amsterdam 30
Johannesburg 30
Denver 29
Nanjing 29
Washington 28
Belo Horizonte 27
Atlanta 26
San Francisco 26
Boardman 25
Kent 25
New Delhi 25
Baghdad 24
Montreal 24
Parma 23
Phoenix 23
Porto Alegre 23
Kunming 22
Miami 22
Naples 22
San Mateo 22
Dhaka 21
Napoli 20
Tashkent 20
Toronto 20
Basingstoke 19
Quito 19
Stockholm 19
Brooklyn 18
Jinan 18
Sydney 18
Totale 23.438
Salva come PNG Salva come JPEG
Nome #
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 464
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 447
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 421
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 401
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 392
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 386
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 371
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 369
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 368
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 357
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 339
Bead coating process via an excess of crosslinking agent 335
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 334
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 333
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 330
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 330
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 330
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 328
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 323
Chitosan-alginate microparticles as a protein carrier 323
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 323
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 322
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 316
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 315
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 314
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 313
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 305
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 304
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 298
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 297
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 291
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 288
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 288
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 284
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 284
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 278
Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles 277
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 275
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 274
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 274
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 273
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 272
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 272
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 270
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 269
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 267
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 266
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 263
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 262
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 259
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 259
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 258
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 255
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 253
Protein immobilization in crosslinked alginate microparticles 251
Caratterizzazione chimico-fisica di membrane e feltri di collagene 246
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 245
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 245
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 244
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 242
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 240
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 239
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 235
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 235
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 235
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 234
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 234
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 234
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 233
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 232
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 232
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 231
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 230
Modified PLGA Nanoparticles as drug carriers for CNS delivery 225
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 225
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 221
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 219
Surface drug removal from ibuprofen-loaded PLA microspheres 219
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 218
Caratterizzazione chimico-fisica e studi di stabilità di sistemi lipidici per il transfer genico 218
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 218
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 218
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 216
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 216
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 216
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 209
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres 209
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 208
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 207
Formulazione per veicolare principi attivi lipofili 206
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 205
Development of new formulations of cationic solid lipid nanoparticles (SLNs) for the drug delivery to the brain 205
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 205
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 205
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 202
In vitro behaviour of multicomposite cationic SLN as new platform for pDNA delivery 200
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 197
Drug release from perforated matrices containing hydroxypropylcellulose 195
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoprecipitation method 192
Characterization of cationic SLN/protamine complex as a non-viral transfer vector 191
Totale 27.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021836 0 0 0 0 0 0 0 0 0 436 292 108
2021/20222.585 63 304 233 158 86 174 125 134 314 196 510 288
2022/20232.985 464 350 212 326 337 419 56 243 332 48 113 85
2023/20241.624 77 117 129 161 340 176 161 160 46 38 78 141
2024/20256.582 272 71 187 432 1.203 796 543 499 670 243 748 918
2025/202610.612 780 504 949 1.330 1.828 809 1.491 676 1.297 948 0 0
Totale 35.104